Sluttelig konkluderede CHMP, at virkningen opvejer produktets toksicitet, og at benefit/ risk- forholdet er positivt.
In conclusion, the CHMP considered that this efficacy outweighs the toxicity of the product, and that the benefit/ risk balance is positive.